Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $214.68 USD
Change Today +0.69 / 0.32%
Volume 584.4K
GEVA On Other Exchanges
As of 12:50 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sanj K. Patel

Chief Executive Officer, President, Secretary and Director, Synageva BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Sanj K. Patel has been the President and Chief Executive Officer of Synageva BioPharma Corp. since June 2008 and serves as its Secretary. Mr. Patel has 18 years of experience in the pharmaceutical and biotech industries. He joined Synageva from Genzyme Corporation from 1999 to 2008, where most recently, he served as the Head of US Sales, Marketing and Commercial Operations for Genzyme Therapeutics and led the commercial US launch for Myozyme®. Previously, he held ...

Read Full Background

Corporate Headquarters*

33 Hayden Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-357-9900
Fax: 781-357-9901

Board Members Memberships*

Chief Executive Officer, President, Secretary and Director
Director and Member of Compensation Committee


King's College
London South Bank University
Master's Degree
Ealing, Hammersmith and West London College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$631,176

Stock Options*

All Other Compensation$11,950
Exercised Options152,300
Exercised Options Value$12,677,365
Exercisable Options245,932
Exercisable Options Value$14,931,054
Unexercisable Options308,632
Unexercisable Options Value$12,526,993
Total Value of Options$40,135,412
Total Number of Options706,864

Total Compensation*

Total Annual Cash Compensation$1,040,767
Total Short Term Compensation$631,176
Other Long Term Compensation$11,950
Total Calculated Compensation$7,069,567
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GEVA:US $214.68 USD +0.69


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNAGEVA BIOPHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at